JAK inhibitors for treatment of myeloproliferative disorders

Details for Australian Patent Application No. 2007275562 (hide)

Owner Cephalon, Inc.

Inventors Ruggeri, Bruce A.; Dobrzanski, Pawel

Agent Watermark

Pub. Number AU-A-2007275562

PCT Pub. Number WO2008/011174

Priority 60/832,627 21.07.06 US; 11/880,063 19.07.07 US

Filing date 20 July 2007

Wipo publication date 24 January 2008

International Classifications

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/011174 Priority application(s): WO2008/011174

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007275565-Medicinal delivery system and related methods

2007275561-Improvement of arginase levels/activity